Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.370
-0.050 (-3.52%)
Nov 20, 2024, 4:00 PM EST - Market closed
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $188.50 million as of November 21, 2024. Its market cap has decreased by -15.93% in one year.
Market Cap
188.50M
Enterprise Value
59.97M
1-Year Change
-15.93%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $188.50M, a decrease of -56.70%. That is a compound annual growth rate of -20.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 195.38M | -1.74% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 194.83M |
| Lexeo Therapeutics | 194.43M |
| Profound Medical | 194.34M |
| Orchestra BioMed Holdings | 193.87M |
| InfuSystem Holdings | 192.22M |
| Nektar Therapeutics | 187.23M |
| Sight Sciences | 186.78M |
| Nanobiotix | 184.29M |